DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Pfizer (NYSE: PFE)

32.80 0.35 (1.08%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $32.80 1.08%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.47
Previous Close $32.45
Daily Range $32.17 - $32.85
52-Week Range $27.51 - $33.50
Market Cap $206.7B
P/E Ratio 20.03
Dividend (Yield) $1.12 (3.5%)
Ex-Dividend Date
Dividend Pay Date
02/04/15
03/03/15
Volume 26,834,747
Average Daily Volume 26,098,315
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog

Pfizer Commits to Further Reduce Price for Prevenar 13 in the World's Poorest Countries Through 2025

Pre-Market Earnings Report for January 27, 2015 : PG, PFE, UTX, MMM, BMY, DD, LMT, DHR, CAT, NEE, A

Pre-Market Earnings Report for January 27, 2015 : PG, PFE, UTX, MMM, BMY, DD, LMT, DHR, CAT, NEE, AAL, ERIC

Bristol Myers Squibb: What To Expect In Q4 2014 And Beyond

United Technologies moves up earnings release because of weather

What to Expect When Pfizer (PFE) Reports Fourth-Quarter Earnings Tomorrow

This Stock Could Become the Next Johnson & Johnson

Our Motley Fool contributors think that these three companies could one day be as revered as J&J.

Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog

Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog

See More PFE News...

PFE's Top Competitors

PFE $32.80 (1.08%)
Current stock: PFE
JNJ $102.26 (0.06%)
Current stock: JNJ
ROG $77.58 (1.94%)
Current stock: ROG
GSK $45.19 (0.40%)
Current stock: GSK